Mikania laevigata
Mikania laevigata · Accepted scientific name
Scientific literature: Very Sparse (6 studies) · ★☆☆☆☆
Mikania laevigata is a versatile medicinal plant known for its diverse range of pharmacological activities, including antibacterial, anticoagulant, and antiparasitic properties. The plant's therapeutic potential is driven by key chemical constituents such as coumarin, 1-octadecene, ent-kaurenoic acid, and o-coumaric acid. Researchers often utilize the leaves to develop various preparations, ranging from aqueous and ethanolic extracts to specific hexane and ethyl acetate fractions. These bioactive components are frequently studied for their ability to address medical conditions like asthma, bronchitis, and various parasitic infections. Consequently, this species serves as a significant subject in the search for natural antipyretic and antisyphilitic treatments.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Africa
- Plant Parts
- Leaf
Classification
Synonyms
Mikania laevigata is a climbing plant that is frequently identified in botanical literature by its synonym, Cacalia nitida. While these names may appear distinct, they refer to the exact same biological species within the Asteraceae family. Understanding these taxonomic shifts is essential for researchers tracking the plant's distribution and ecological role. Navigating these historical naming conventions ensures that scientific data remains consistent across different studies. Ultimately, recognizing both terms allows for a clearer connection between older botanical records and modern classifications.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Mikania laevigata is a fascinating organism belonging to the vast kingdom Plantae. Within this biological kingdom, the plant is classified under the class Equisetopsida. It further falls into the order Asterales, showcasing its evolutionary lineage. As a member of the genus Mikania, it displays unique morphological traits characteristic of its group. Finally, this species is nested within the diverse family Asteraceae, connecting it to a wide array of other flowering plants.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Mikania |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Mikania laevigata is a plant species primarily found within the diverse landscapes of South America. Its presence is most notably documented across various regions of Brazil, showcasing a wide geographic footprint. Specifically, the plant thrives in the southeastern parts of the country, contributing to local biodiversity. It also maintains a significant distribution throughout Brazil's west-central territories. This broad range across Brazil highlights the adaptable nature of the species within its natural habitat.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Mikania laevigata is characterized by an obligatory climbing habit, meaning it relies entirely on other structures for support to reach the sunlight it needs to thrive.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Mikania laevigata, commonly known as guaco, possesses a diverse range of biological activities that make it a significant subject of pharmacological interest. In traditional Brazilian medicine, the plant is widely utilized as an effective natural bronchodilator to treat various upper respiratory conditions. Scientific studies have also highlighted its potential as an anticoagulant, noting its effects on prothrombin time in laboratory settings. Furthermore, the species has demonstrated medicinal properties including antibacterial and antiparasitic activities, though the efficacy of the former remains a subject of some debate. While its use as an antisyphilitic is noted in popular tradition, researchers suggest that more clinical evidence is needed to fully validate this specific application.
Compounds
Mikania laevigata is a medicinal plant that possesses a complex chemical profile containing several bioactive compounds. Scientific analysis has identified that this species contains coumarin, which contributes to its various therapeutic properties. Furthermore, the plant is known to contain 1-octadecene, a compound found within its chemical extracts. Research also highlights that Mikania laevigata contains o-coumaric acid, specifically quantified in standardized hydroalcoholic dried extracts. Together, these constituents support the plant's potential use in developing antimicrobial agents and antiulcerogenic phytopharmaceutical products.
Conditions
Mikania laevigata is widely utilized in herbal medicine to treat respiratory conditions such as asthma, bronchitis, and the common cold. This plant also demonstrates significant anti-ulcerogenic properties, contributing to its diverse medicinal profile. Furthermore, scientific studies have shown that its infusions can treat mutagenic effects by inhibiting damage specifically induced by the 2AF mutagen. These varied therapeutic applications highlight the plant's importance in addressing both respiratory and cellular health issues.
Preparations
Mikania laevigata is prepared as aqueous extracts to screen for mutagenic activity and to test for the inhibition of mutagenesis. Researchers also utilize ethanolic extracts and general extracts of the plant to evaluate its chemical composition and biological activities. Furthermore, the plant is processed into hexane and ethyl acetate fractions to identify specific antimicrobial compounds. In some studies, Mikania laevigata is prepared specifically as a hexane extract of aerial parts to isolate derivatives like kaurenoic acid. These various preparation methods allow for the comprehensive study of the plant's potential as an antimicrobial agent and a protector of DNA.
Parts used
Mikania laevigata is a medicinal plant highly valued for its therapeutic properties, particularly through the use of its leaves. Scientific research highlights that the leaves serve as a primary source of bioactive compounds, including coumarin and various kaurane-type diterpenes. These essential chemical constituents are often analyzed using advanced methods like RP-HPLC to ensure precise quantification for pharmaceutical use. Studies have also demonstrated that the volatile profile of the leaves can fluctuate based on environmental factors such as temperature, light, and water availability. Ultimately, processing these leaves into standardized extracts shows great promise for developing effective treatments for respiratory and gastroprotective applications.